Bárbara Meléndez

2.4k total citations
66 papers, 1.6k citations indexed

About

Bárbara Meléndez is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Bárbara Meléndez has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Genetics and 19 papers in Neurology. Recurrent topics in Bárbara Meléndez's work include Glioma Diagnosis and Treatment (27 papers), Epigenetics and DNA Methylation (16 papers) and Meningioma and schwannoma management (10 papers). Bárbara Meléndez is often cited by papers focused on Glioma Diagnosis and Treatment (27 papers), Epigenetics and DNA Methylation (16 papers) and Meningioma and schwannoma management (10 papers). Bárbara Meléndez collaborates with scholars based in Spain, United States and Brazil. Bárbara Meléndez's co-authors include Manuela Mollejo, Ángel Rodríguez de Lope, Concepción Fiaño, Juan A. Rey, Teresa Ribalta, Yolanda Ruano, Isabelle Salmon, Nicky D’Haene, Javier S. Castresana and Claude Van Campenhout and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Bárbara Meléndez

64 papers receiving 1.6k citations

Peers

Countries citing papers authored by Bárbara Meléndez

Since Specialization

Citations

This map shows the geographic impact of Bárbara Meléndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bárbara Meléndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bárbara Meléndez more than expected).

Fields of papers citing papers by Bárbara Meléndez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bárbara Meléndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bárbara Meléndez. The network helps show where Bárbara Meléndez may publish in the future.

Co-authorship network of co-authors of Bárbara Meléndez

This figure shows the co-authorship network connecting the top 25 collaborators of Bárbara Meléndez. A scholar is included among the top collaborators of Bárbara Meléndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bárbara Meléndez. Bárbara Meléndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib 2025 ·Cancers ·Ana M Muñoz‐Mármol, Bárbara Meléndez, Ainhoa Hernández, Carolina Sanz, Marta Doménech, (unknown), Marta Gut, Anna Esteve, Anna Esteve‐Codina, Genı́s Parra, Cristina Carrato, Ibán Aldecoa, Mar Mallo, Estela Pineda, Francesc Alameda, Núria de la Iglesia, Eva Martinez‐Balibrea, Anna Martínez‐Cardús, (unknown), Carmen Balañá	2
2	The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation 2024 ·Cancers ·(unknown), (unknown), Estela Pineda, Ainhoa Hernández, Marta Doménech, Carolina Sanz, Pedro Jares, Ana M Muñoz‐Mármol, (unknown), Bárbara Meléndez, Marta Gut, Anna Esteve, Anna Esteve‐Codina, Genı́s Parra, Francesc Alameda, Cristina Carrato, Ibán Aldecoa, Mar Mallo, Núria de la Iglesia, Carmen Balañá	1
3	Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines 2021 ·Biology ·(unknown), (unknown), María Victoria Zelaya, Idoya Zazpe, José L. Lanciego, Bárbara Meléndez, Juan A. Rey, Miguel Á. Idoate, Natalia A. Riobo‐Del Galdo, Javier S. Castresana	11
4	Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas 2019 ·Cancers ·Nicky D’Haene, Bárbara Meléndez, (unknown), Nancy De Nève, Laetitia Lebrun, Claude Van Campenhout, Isabelle Salmon	20
5	Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups 2019 ·American Journal of Neuroradiology ·Julián Pérez-Beteta, David Molina-García, (unknown), (unknown), Carlos Velásquez, Juan Martino, Bárbara Meléndez, Ángel Rodríguez de Lope, (unknown), Juan Manuel Sepúlveda-Sánchez, Aurelio Hernández‐Laín, Ana Ramos, Juan A. Barcia, Pedro C. Lara, (unknown), Antonio Revert, Estanislao Arana, Victor M. Pérez-Garcı́a	12
6	Panobinostat Potentiates Temozolomide Effects and Reverses Epithelial–Mesenchymal Transition in Glioblastoma Cells 2018 ·Epigenomes ·(unknown), Bárbara Meléndez, Juan A. Rey, Miguel Á. Idoate, Javier S. Castresana	7
7	Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line 2016 ·Tumor Biology ·(unknown), Ander Saenz‐Antoñanzas, Mehdi Hayat Shahi, Bárbara Meléndez, Juan A. Rey, Javier S. Castresana	5
8	Genome-Wide Microarray Expression and Genomic Alterations by Array-CGH Analysis in Neuroblastoma Stem-Like Cells 2014 ·PLoS ONE ·Raquel Ordóñez, Gabriel Gallo-Oller, (unknown), (unknown), (unknown), Justine Guégan, (unknown), Alain Bernheim, Bárbara Meléndez, Juan A. Rey, Javier S. Castresana	4
9	Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples 2014 ·Tumor Biology ·Mehdi Hayat Shahi, Idoya Zazpe, Mohammad Afzal, Subrata Sinha, Robert B. Rebhun, Bárbara Meléndez, Juan A. Rey, Javier S. Castresana	12
10	Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component 2014 ·Molecular Cytogenetics ·Miguel Torres‐Martín, (unknown), Fernando Carceller, Manuel Gutiérrez, Rommel Mário Rodríguez Burbano, Giovanny R. Pinto, Javier S. Castresana, Bárbara Meléndez, Juan A. Rey	10
11	Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue 2014 ·Oncology Reports ·Miguel Torres‐Martín, Luis Lassaletta, Alberto Isla, José M. de Campos, Giovanny R. Pinto, Rommel Mário Rodríguez Burbano, Javier S. Castresana, Bárbara Meléndez, Juan A. Rey	14
12	Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in Those Included in Chromosomal Region 14q32 2013 ·PLoS ONE ·Miguel Torres‐Martín, Luis Lassaletta, José M. de Campos, Alberto Isla, Javiér Gavilán, Giovanny R. Pinto, Rommel Mário Rodríguez Burbano, Farida Latif, Bárbara Meléndez, Javier S. Castresana, Juan A. Rey	31
13	Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas 2012 ·Clinical & Translational Oncology ·Miguel Torres‐Martín, Víctor Martínez‐Glez, (unknown), Luis Lassaletta, Alberto Isla, José M. de Campos, Giovanny R. Pinto, Rommel Mário Rodríguez Burbano, Bárbara Meléndez, Javier S. Castresana, Juan A. Rey	7
14	Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death 2011 ·Autophagy ·Mar Lorente, Sofía Torres, María Salazar‐Roa, Arkaitz Carracedo, Sonia Hernández‐Tiedra, Fátima Rodríguez-Fornés, Elena García-Taboada, Bárbara Meléndez, Manuela Mollejo, Yolanda Campos‐Martín, Juan A. Barcia, Manuel Guzmán, Guillermo Velasco	24
15	Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling 2006 ·Molecular Cancer ·Yolanda Ruano, Manuela Mollejo, Teresa Ribalta, Concepción Fiaño, Francisca I. Camacho, (unknown), Ángel Rodríguez de Lope, (unknown), Pedro Martı́nez, Bárbara Meléndez	102
16	Gene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridization 2004 ·Genes Chromosomes and Cancer ·Bárbara Meléndez, Ramón Díaz‐Uriarte, Marta Cuadros, Ángel Martínez‐Ramírez, José Fernández‐Piqueras, Ana Dopazo, (unknown), Carmen Rivas, Joaquı́n Dopazo, Beatriz Martı́nez-Delgado, Javier Benı́tez	13
17	Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1) 2003 ·Human Genetics ·Bárbara Meléndez, Sandra Rodríguez, Beatriz Martı́nez-Delgado, (unknown), Mercedes Robledo, Ángel Martínez‐Ramírez, Sergio Ruiz‐Llorente, Miguel Urioste, Juan C. Cigudosa, Javier Benı́tez	14
18	Fulminant Septic Shock in AIDS Patients Caused by Disseminated Cryptococcosis 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·Fernando Lozano, Jesús Gómez‐Mateos, José Antonio Irles Rocamora, Bárbara Meléndez, (unknown)	2
19	Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage 1997 ·Cancer Genetics and Cytogenetics ·José Fernández‐Piqueras, Javier Santos, Ignacío Pérez de Castro, Bárbara Meléndez, (unknown), Mercedes Robledo, Carmen Rivas, Javier Benı́tez	13
20	Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas 1997 ·Oncogene ·Marcos Malumbres, Ignacío Pérez de Castro, Javier Santos, Bárbara Meléndez, Ramón Mangues, Manuel Serrano, Àngel Pellicer, José Fernández‐Piqueras	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact